Affordable Access

deepdyve-link deepdyve-link
Publisher Website

A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden.

Authors
  • Lindström, Eva
  • Eberhard, Jonas
  • Fors, Björn M
  • Hansen, Karina
  • Sapin, Christophe
Type
Published Article
Journal
Nordic Journal of Psychiatry
Publisher
Informa UK (Taylor & Francis)
Publication Date
Dec 01, 2011
Volume
65
Issue
6
Pages
403–413
Identifiers
DOI: 10.3109/08039488.2011.590603
PMID: 21770821
Source
Medline
License
Unknown

Abstract

The relatively good tolerability profile of sertindole translates into lower costs of schizophrenia management, primarily driven by substantially lower direct and indirect costs. Sertindole appears to be a clinically and cost-effective alternative in the management of patients with schizophrenia in Sweden.

Report this publication

Statistics

Seen <100 times